Bristol-Myers Hits Sandoz Over Generic Hepatitis Drug
Bristol-Myers Squibb Co. on Thursday filed suit in Delaware federal court alleging Sandoz Inc.'s plan to make a generic version of the hepatitis B drug Baraclude would lead to infringement of...To view the full article, register now.
Already a subscriber? Click here to view full article